Goodbody Health Limited announced that it has partnered with Datar Cancer Genetics ("Datar") a liquid biopsy company to offer its innovative Circulating Tumor Cell (CTC) based multi-cancer screening solution Trucheck in the UK.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | +9,900.00% | -.--% | -66.67% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-66.67% | 3.65K | |
+39.50% | 6.23B | |
+5.32% | 3.32B | |
-18.39% | 2.91B | |
-6.41% | 2.42B | |
+42.43% | 1.94B | |
-14.15% | 1.59B | |
-4.27% | 1.58B | |
+38.37% | 1.49B | |
-15.57% | 1.48B |
- Stock Market
- Equities
- GDBYF Stock
- News Goodbody Health Limited
- Goodbody Health Limited Partners with Datar to Offer Innovative Cancer Screening